July 6, 2012
-- The order is one of the more significant for ConsiGma™ oral solid dosage continuous processing equipment and represents the first phase of a potentially long-term commitment for this customer. Delivery is scheduled for early 2013.
The order is to deliver a continuous solid dosage production platform, including continuous blending, wet granulation and drying, dry granulation and direct compression. In addition to the Courtoy™ MODUL™ tablet press and a tablet relaxation module, the system will also include the first commercial continuous GEA coater. The entire line will be equipped with a range of PAT instruments (partly based on the GEA’s patented Lighthouse Probe™ technology) for on-line measurement of particle size distribution, humidity, blend/content uniformity and coating quality. This data will be captured in an overall control and information system which allows for ‘real-time-
release’ of the finished tablets.
Jan Vugts, Managing Director of GEA Pharma Systems in Wommelgem, Belgium said, “We were all delighted to receive the order. GEA has many years’ experience with continuous processing in other industries and GPS is a market leader in batch granulation, drying and compression technologies for the pharma industry. I believe this experience and the expertise of the team in our global competence centre near Antwerp, Belgium have greatly contributed to the confidence this customer has shown in GPS.”
GEA Pharma Systems has been the leader in continuous processing technology since the introduction of ConsiGma™ in 2008 and has supplied over 15 production systems in the market.